Ujjwala Yadav Kandekar
Research Subjects
Ujjwala Yadav Kandekar has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Neha Manish Munot
Department of Pharmaceutics, School of Pharmacy, Vishwakarma University, Pune 411048, Maharashtra, India
4 shared publications - Ashlesha Pravin Pandit
Department of Pharmaceutics, JSPM’s Rajarshi Shahu College of Pharmacy and Research, Tathawade, Pune, India
3 shared publications Ashlesha Pandit
Department of Pharmaceutics, JSPM’s Rajarshi Shahu College of Pharmacy and Research, Tathawade, Pune, India
2 shared publications- Aarati R. Supekar
Dr. D Y Patil Dnyan Prasad University’s, School of Pharmacy and Research, Pune, Gaikwad Haraibhau Vinayan Rd, Sant Tukaram Nagar, Pimpri Colony, Pimpri, Chinchwad, Maharashtra, Pune, India
1 shared publication - Abhinandan Patil
D. Y. Patil College of Pharmacy, D. Y. Patil Education Society, Deemed to be University, Kolhapur 416006, Maharashtra, India
1 shared publication - Abhinandan Patil
Department of Pharmaceutics, School of Pharmacy, Sanjay Ghodawat University, Kolhapur 416118, Maharashtra, India
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3  (1) , 573
Amixicile loaded polyvinyl alcohol and pullulan composite film for localized periodontal treatment
- 9 October 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3  (1) , 573
Open AccessAmixicile loaded polyvinyl alcohol and pullulan composite film for localized periodontal treatment
- Open Access
- 30 June 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15  (2)
Lemongrass Oil-Based Microemulgel of Luliconazole: Formulation and Antifungal Assessment
This research work is focused on the development of luliconazole-loaded microemulgel using lemongrass oil to enhance its topical delivery. Different microemulsion formulations were prepared based on pseudoternary phase diagrams by varying the amounts of lemongrass oil, Labrasol, and Labrafil M 2125 CS, and evaluated. An optimized formulation was selected based on systematic comparison of evaluation parameters, loaded into 1% Carbopol 940 gel, and examined. pH, viscosity, drug content, and in-vitro diffusion for microemulsions ranged from 5.1±0.15 to 5.6±0.11, 41±1.5 to 48±1.5 cP, 97±0.21 to 98±0.67%, and 58±1.82 to 86±2.18%, respectively. Among four formulations, the F1 formulation was selected as the optimized formulation as it exhibits pH, viscosity, and drug content of 5.4±0.10, 41±1.5, and 98±0.44%, respectively. Results showed that optimized microemulsion exhibited pH, viscosity, drug content, and drug diffusion of 5.4±0.10, 41±1.5cP, 98±0.44%, and 86±2.18%, respectively. Particle size and zeta potential of optimized microemulsion were 187.9nm and -34.4mV, respectively. pH, viscosity, drug content, in-vitro diffusion, and ex-vivo diffusion of microemulgel were 6.0±0.11, 10032±1.5cP, 98±0.44%, 71±0.95%, and 68±2.06%, respectively. Zone of inhibition for the prepared microemulgel and the marketed gel was 29 and 26mm, respectively. These results demonstrated that the combination of luliconazole with lemongrass oil in an emulsion formulation enhanced antifungal activity.
- 30 June 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15  (2)
Open AccessLemongrass Oil-Based Microemulgel of Luliconazole: Formulation and Antifungal Assessment
This research work is focused on the development of luliconazole-loaded microemulgel using lemongrass oil to enhance its topical delivery. Different microemulsion formulations were prepared based on pseudoternary phase diagrams by varying the amounts of lemongrass oil, Labrasol, and Labrafil M 2125 CS, and evaluated. An optimized formulation was selected based on systematic comparison of evaluation parameters, loaded into 1% Carbopol 940 gel, and examined. pH, viscosity, drug content, and in-vitro diffusion for microemulsions ranged from 5.1±0.15 to 5.6±0.11, 41±1.5 to 48±1.5 cP, 97±0.21 to 98±0.67%, and 58±1.82 to 86±2.18%, respectively. Among four formulations, the F1 formulation was selected as the optimized formulation as it exhibits pH, viscosity, and drug content of 5.4±0.10, 41±1.5, and 98±0.44%, respectively. Results showed that optimized microemulsion exhibited pH, viscosity, drug content, and drug diffusion of 5.4±0.10, 41±1.5cP, 98±0.44%, and 86±2.18%, respectively. Particle size and zeta potential of optimized microemulsion were 187.9nm and -34.4mV, respectively. pH, viscosity, drug content, in-vitro diffusion, and ex-vivo diffusion of microemulgel were 6.0±0.11, 10032±1.5cP, 98±0.44%, 71±0.95%, and 68±2.06%, respectively. Zone of inhibition for the prepared microemulgel and the marketed gel was 29 and 26mm, respectively. These results demonstrated that the combination of luliconazole with lemongrass oil in an emulsion formulation enhanced antifungal activity.
- Open Access
- 30 January 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 121-129
Bridging Ayurveda and Bioinformatics: Unveiling the Antiviral Potential of Glycyrrhizic Acid Through Molecular Docking
Background: Ayurveda has a substantial collection of bioactive substances with potential therapeutic benefits, although their molecular processes frequently remain unexplored. Glycyrrhizic acid, a primary component of Glycyrrhiza glabra (Liquorice), was historically acknowledged for its antiviral characteristics. The integration of Ayurvedic expertise with bioinformatic techniques offers a novel method for the scientific validation of these substances. Aim: This study investigates the antiviral potential of Glycyrrhizic acid, a major bioactive constituent of G. glabra (Liquorice) widely employed in Ayurvedic medicine, through integrated computational and molecular docking analyses. Method: Molecular docking studies were performed against key viral targets, such as the Adenosine Triphosphate (ATP)-bound state of BiP (5E84), main protease (Mpro) (6LU7), spike receptor binding domain (6LZG), RNA-dependent RNA polymerase (6M71), spike glycoprotein (6VSB), NSP15 endonuclease (6VWW), Nsp9 RNA-binding protein (6W4B), papain like protease (6W9C), and neurominadase from H1N1 (5NZ4); which are involved in replication, proteolysis, and host-virus interactions were chosen because of their biological importance and structural availability in the Protein Data Bank. Result: Our results demonstrate that Glycyrrhizic acid exhibits superior binding affinity compared to the standard antiviral drug ribavirin, particularly against the spike receptor-binding domain (6LZG) with a docking score of -10.307 kcal/mol. These findings were confirmed by Molecular Mechanics/ Generalised Born Surface Area (MM-GBSA) calculations, which showed stable ligand-receptor complexes and advantageous binding free energy components. Conclusion: The potential of Glycyrrhizic acid as an antiviral drug is highlighted in this work, which also shows the value of combining contemporary bioinformatics techniques with Ayurvedic phytochemistry. The hypothesised antiviral pathways will be experimentally validated in future in vitro and in vivo research using the computational insights as a basis. Major Findings: Molecular docking analysis revealed that Glycyrrhizic acid exhibits strong binding affinity with key viral target proteins, indicating significant antiviral potential.
- 30 January 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 121-129
Open AccessBridging Ayurveda and Bioinformatics: Unveiling the Antiviral Potential of Glycyrrhizic Acid Through Molecular Docking
Background: Ayurveda has a substantial collection of bioactive substances with potential therapeutic benefits, although their molecular processes frequently remain unexplored. Glycyrrhizic acid, a primary component of Glycyrrhiza glabra (Liquorice), was historically acknowledged for its antiviral characteristics. The integration of Ayurvedic expertise with bioinformatic techniques offers a novel method for the scientific validation of these substances. Aim: This study investigates the antiviral potential of Glycyrrhizic acid, a major bioactive constituent of G. glabra (Liquorice) widely employed in Ayurvedic medicine, through integrated computational and molecular docking analyses. Method: Molecular docking studies were performed against key viral targets, such as the Adenosine Triphosphate (ATP)-bound state of BiP (5E84), main protease (Mpro) (6LU7), spike receptor binding domain (6LZG), RNA-dependent RNA polymerase (6M71), spike glycoprotein (6VSB), NSP15 endonuclease (6VWW), Nsp9 RNA-binding protein (6W4B), papain like protease (6W9C), and neurominadase from H1N1 (5NZ4); which are involved in replication, proteolysis, and host-virus interactions were chosen because of their biological importance and structural availability in the Protein Data Bank. Result: Our results demonstrate that Glycyrrhizic acid exhibits superior binding affinity compared to the standard antiviral drug ribavirin, particularly against the spike receptor-binding domain (6LZG) with a docking score of -10.307 kcal/mol. These findings were confirmed by Molecular Mechanics/ Generalised Born Surface Area (MM-GBSA) calculations, which showed stable ligand-receptor complexes and advantageous binding free energy components. Conclusion: The potential of Glycyrrhizic acid as an antiviral drug is highlighted in this work, which also shows the value of combining contemporary bioinformatics techniques with Ayurvedic phytochemistry. The hypothesised antiviral pathways will be experimentally validated in future in vitro and in vivo research using the computational insights as a basis. Major Findings: Molecular docking analysis revealed that Glycyrrhizic acid exhibits strong binding affinity with key viral target proteins, indicating significant antiviral potential.
- Open Access
- 20 June 2025
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 66  (3) , 288-300
Formulation and evaluation of stiripentol oral suspension
IntroducciĂłn: El trabajo de investigaciĂłn se llevĂł a cabo para desarrollar una suspensiĂłn estable y eficaz de estiripentol para el tratamiento de la epilepsia. MĂ©todo: Se utilizĂł el estudio FT-IR para evaluar la compatibilidad entre el fármaco y el excipiente y tambiĂ©n se examinĂł la apariencia fĂsica de la mezcla del fármaco y el excipiente despuĂ©s de un mes de estudio de estabilidad. La suspensiĂłn se preparĂł mediante un agitador mecánico y se evaluĂł la viscosidad, el pH, el volumen de sedimentaciĂłn, el potencial zeta y los estudios de liberaciĂłn de fármaco in vitro. La formulaciĂłn optimizada se evaluĂł adicionalmente para determinar el potencial zeta y el Ăndice de polidispersidad. Resultados: Los resultados de FT-IR confirmaron la compatibilidad del fármaco y los excipientes. La apariencia fĂsica de la mezcla no se alterĂł durante las condiciones de almacenamiento aceleradas. La viscosidad, el pH y el volumen de sedimentaciĂłn de la formulaciĂłn oscilaron entre 22,92 ±1,2 cPs y 54,8 ± 2,1 cPs; 5,32 ± 0,04 y 6,01 ± 0,1 y 83,19 ± 0,9 % y 98,87 ± 1,2 % respectivamente. El potencial zeta y el Ăndice de polidispersidad de la formulaciĂłn optimizada fueron -52,1 mV y 0,198 respectivamente. Estos resultados fueron indicativos de una suspensiĂłn monodispersa estable. La formulaciĂłn optimizada fue estable a temperaturas y humedad más altas y en presencia de luz, lo que indica una buena vida Ăştil. Conclusiones: El estudio demostrĂł que la suspensiĂłn oral de estiripentol puede formularse como una forma farmacĂ©utica estable y eficaz para el tratamiento de la epilepsia.
- 20 June 2025
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 66  (3) , 288-300
Open AccessFormulation and evaluation of stiripentol oral suspension
IntroducciĂłn: El trabajo de investigaciĂłn se llevĂł a cabo para desarrollar una suspensiĂłn estable y eficaz de estiripentol para el tratamiento de la epilepsia. MĂ©todo: Se utilizĂł el estudio FT-IR para evaluar la compatibilidad entre el fármaco y el excipiente y tambiĂ©n se examinĂł la apariencia fĂsica de la mezcla del fármaco y el excipiente despuĂ©s de un mes de estudio de estabilidad. La suspensiĂłn se preparĂł mediante un agitador mecánico y se evaluĂł la viscosidad, el pH, el volumen de sedimentaciĂłn, el potencial zeta y los estudios de liberaciĂłn de fármaco in vitro. La formulaciĂłn optimizada se evaluĂł adicionalmente para determinar el potencial zeta y el Ăndice de polidispersidad. Resultados: Los resultados de FT-IR confirmaron la compatibilidad del fármaco y los excipientes. La apariencia fĂsica de la mezcla no se alterĂł durante las condiciones de almacenamiento aceleradas. La viscosidad, el pH y el volumen de sedimentaciĂłn de la formulaciĂłn oscilaron entre 22,92 ±1,2 cPs y 54,8 ± 2,1 cPs; 5,32 ± 0,04 y 6,01 ± 0,1 y 83,19 ± 0,9 % y 98,87 ± 1,2 % respectivamente. El potencial zeta y el Ăndice de polidispersidad de la formulaciĂłn optimizada fueron -52,1 mV y 0,198 respectivamente. Estos resultados fueron indicativos de una suspensiĂłn monodispersa estable. La formulaciĂłn optimizada fue estable a temperaturas y humedad más altas y en presencia de luz, lo que indica una buena vida Ăştil. Conclusiones: El estudio demostrĂł que la suspensiĂłn oral de estiripentol puede formularse como una forma farmacĂ©utica estable y eficaz para el tratamiento de la epilepsia.
- 5 June 2025
- Published by Springer Nature in BioNanoScience
- Vol. 15  (3) , 1-14
Novel Aspasomal Gel Formulation with Enhanced Dapsone Solubility for Effective Treatment of Acne
- 5 June 2025
- Published by Springer Nature in BioNanoScience
- Vol. 15  (3) , 1-14
Novel Aspasomal Gel Formulation with Enhanced Dapsone Solubility for Effective Treatment of Acne
- 29 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 104
Optimization of invasomal gel of miconazole nitrate for the treatment of topical fungal infections
- 29 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 104
Optimization of invasomal gel of miconazole nitrate for the treatment of topical fungal infections
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21  (2) , 141-151
Flaxseed Mucilage/Hydroxypropyl Methylcellulose and Sodium Alginate/Polyvinyl Alcohol Composite Bilayer Film as a Promising Drug Carrier for Periodontal Treatment
The present study focused on the formulation of mucoadhesive bilayer composite films for the treatment of periodontitis and evaluation of their physicochemical properties. The solvent casting technique was used to prepare films. The primary layer (D) was prepared with flaxseed and hydroxypropyl methylcellulose composite to sustain the release of doxycycline hyclate. The second layer (S) comprised sodium alginate and polyvinyl alcohol composite for faster release of clove oil. Both layers were combined to generate the bilayer film (B). All formulations were characterized further to obtain an optimized formulation. Attenuated total reflection-Fourier transform infrared radiation results showed intactness of drug and clove oil in the presence of excipients. The pH of the films was compatible with the periodontal cavity and the thickness was suitable for inserting into the cavity. The immediate release layer showed faster disintegration and swelling. The content of clove oil was above 80%. The rate of swelling of the primary layer was slow and drug content complied with the United States Pharmacopoeia. Scanning electron microscope analysis revealed intact, non-porous and smooth films. Films exhibited better mechanical strength and bioadhesiveness. Clove oil was released from the immediate release layer within 10 min, and doxycycline hyclate release was retarded to a minimum of up to 8 h in the primary layer as well as the bilayer. Formulation also had a significant effect on both Escherichia coli and Staphylococcus aureus. In the current study, bilayers were successfully prepared and characterized. The optimized formulation can be effectively used for the treatment of periodontitis.
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21  (2) , 141-151
Flaxseed Mucilage/Hydroxypropyl Methylcellulose and Sodium Alginate/Polyvinyl Alcohol Composite Bilayer Film as a Promising Drug Carrier for Periodontal Treatment
The present study focused on the formulation of mucoadhesive bilayer composite films for the treatment of periodontitis and evaluation of their physicochemical properties. The solvent casting technique was used to prepare films. The primary layer (D) was prepared with flaxseed and hydroxypropyl methylcellulose composite to sustain the release of doxycycline hyclate. The second layer (S) comprised sodium alginate and polyvinyl alcohol composite for faster release of clove oil. Both layers were combined to generate the bilayer film (B). All formulations were characterized further to obtain an optimized formulation. Attenuated total reflection-Fourier transform infrared radiation results showed intactness of drug and clove oil in the presence of excipients. The pH of the films was compatible with the periodontal cavity and the thickness was suitable for inserting into the cavity. The immediate release layer showed faster disintegration and swelling. The content of clove oil was above 80%. The rate of swelling of the primary layer was slow and drug content complied with the United States Pharmacopoeia. Scanning electron microscope analysis revealed intact, non-porous and smooth films. Films exhibited better mechanical strength and bioadhesiveness. Clove oil was released from the immediate release layer within 10 min, and doxycycline hyclate release was retarded to a minimum of up to 8 h in the primary layer as well as the bilayer. Formulation also had a significant effect on both Escherichia coli and Staphylococcus aureus. In the current study, bilayers were successfully prepared and characterized. The optimized formulation can be effectively used for the treatment of periodontitis.
- Open Access
- 30 March 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21  (1) , 295-316
Comprehensive Review on COVID-19 associated Mucormycosis: Diagnosis, Types and Treatment
Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.
- 30 March 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21  (1) , 295-316
Open AccessComprehensive Review on COVID-19 associated Mucormycosis: Diagnosis, Types and Treatment
Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.
- 12 August 2023
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 18  (4) , 1926-1940
Carvedilol-Loaded Cubosome Gel to Accelerate Wound Healing
- 12 August 2023
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 18  (4) , 1926-1940
Carvedilol-Loaded Cubosome Gel to Accelerate Wound Healing
- Open Access
- 20 June 2023
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 64  (3) , 218-229
Development and validation of a high-performance liquid chromatography method for the estimation of esomeprazole in bulk and tablet dosage form
Introduction: An accurate, simple, precise, rapid, economic and reproducible reverse-phase high-performance liquid chromatography method was developed and validated for the estimation of Esomeprazole (ESO) in bulk and tablet dosage form. Method: The separation was carried out on Finepak SIL C18T-5 column (250 × 4.6 mm, 5.0 µm i. d.) using potassium dihydrogen phosphate buffer (0.025M): ACN (20:80 v/v) and at a flow rate of 1.0 mL/min. using UV detector at 302 nm with a run time of 10 min. The method was validated for accuracy for linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ) and robustness. Results: The standard calibration curve was linear with R2 = 0.995. LOD and LOQ obtained for esomeprazole were 0.0001 and 0.0004 µg/mL respectively. The method was found robust for possible changes. Results of analysis of other parameters were also tested and validated as per ICH guidelines and recovery studies confirmed the accuracy of the proposed method. validation studies showed that the developed HPLC method is simple, reproducible, rapid, precise and reliable. The high recovery and low relative standard deviation confirm the suitability of the developed method for the determination of esomeprazole in the tablet dosage form. Conclusion: This method may be used as a more convenient and efficient option for the analysis of esomeprazole to establish the quality of the substance during routine analysis with consistent and reproducible results.
- 20 June 2023
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 64  (3) , 218-229
Open AccessDevelopment and validation of a high-performance liquid chromatography method for the estimation of esomeprazole in bulk and tablet dosage form
Introduction: An accurate, simple, precise, rapid, economic and reproducible reverse-phase high-performance liquid chromatography method was developed and validated for the estimation of Esomeprazole (ESO) in bulk and tablet dosage form. Method: The separation was carried out on Finepak SIL C18T-5 column (250 × 4.6 mm, 5.0 µm i. d.) using potassium dihydrogen phosphate buffer (0.025M): ACN (20:80 v/v) and at a flow rate of 1.0 mL/min. using UV detector at 302 nm with a run time of 10 min. The method was validated for accuracy for linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ) and robustness. Results: The standard calibration curve was linear with R2 = 0.995. LOD and LOQ obtained for esomeprazole were 0.0001 and 0.0004 µg/mL respectively. The method was found robust for possible changes. Results of analysis of other parameters were also tested and validated as per ICH guidelines and recovery studies confirmed the accuracy of the proposed method. validation studies showed that the developed HPLC method is simple, reproducible, rapid, precise and reliable. The high recovery and low relative standard deviation confirm the suitability of the developed method for the determination of esomeprazole in the tablet dosage form. Conclusion: This method may be used as a more convenient and efficient option for the analysis of esomeprazole to establish the quality of the substance during routine analysis with consistent and reproducible results.